|
1.
|
Furnari FB, Fenton T, Bachoo RM, et al:
Malignant astrocytic glioma: genetics, biology, and paths to
treatment. Genes Dev. 21:2683–26710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Porter K, McCarthy B, Berbaum M, et al:
Conditional survival of all primary brain tumor patients by age,
behavior, and histology. Neuroepidemiology. 36:230–239. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Preusser M, de Ribaupierre S, Wöhrer A, et
al: Current concepts and management of glioblastoma. Ann Neurol.
70:9–21. 2011. View Article : Google Scholar
|
|
4.
|
Cheng L, Wu Q, Guryanova O, et al:
Elevated invasive potential of glioblastoma stem cells. Biochem
Biophys Res Commun. 406:643–648. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Louis DN, Ohgaki H, Wiestler OD, et al:
The 2007 WHO classification of tumours of the central nervous
system. Acta Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Stupp R, Mason WP, van den Bent MJ, et al:
Radiotherapy plus concomitant and adjuvant temozolomide for
glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Stupp R, Hegi ME, Mason WP, et al: Effects
of radiotherapy with concomitant and adjuvant temozolomide versus
radiotherapy alone on survival in glioblastoma in a randomised
phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet
Oncol. 10:459–466. 2009.
|
|
8.
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Bakir A, Gezen F, Yildiz O, et al:
Establishment and characterization of a human glioblastoma
multiforme cell line. Cancer Genet Cytogenet. 103:46–51. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Nuki Y, Uchinokura S, Miyata S, et al:
Establishment and characterization of a new human glioblastoma cell
line, NYGM. Hum Cell. 17:145–150. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Wang J, Wang X, Jiang S, et al:
Establishment of a new human glioblastoma multiforme cell line
(WJ1) and its partial characterization. Cell Mol Neurobiol.
27:831–843. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Fomchenko EI and Holland EC: Mouse models
of brain tumors and their applications in preclinical trials. Clin
Cancer Res. 12:5288–5297. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Palumbo O, Palumbo P, Palladino T, et al:
A novel deletion in 2q24.1q24.2 in a girl with mental retardation
and generalized hypotonia: a case report. Mol Cytogenet. 5:12012.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Macchia G, Trombetta D, Möller E, et al:
FOSL1 as a candidate target gene for 11q12 rearrangements in
desmoplastic fibroblastoma. Lab Invest. 92:735–743. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Scintu M, Vitale R, Prencipe M, et al:
Genomic instability and increased expression of BUB1B and MAD2L1
genes in ductal breast carcinoma. Cancer Lett. 254:298–307. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Parrella P, la Torre A, Copetti M, et al:
High specificity of quantitative methylation-specific PCR analysis
for MGMT promoter hypermethylation detection in gliomas. J Biomed
Biotechnol. 2009:5316922009. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Hibi K, Robinson CR, Booker S, et al:
Molecular detection of genetic alterations in the serum of
colorectal cancer patients. Cancer Res. 58:1405–1407.
1998.PubMed/NCBI
|
|
18.
|
Gu TL, Deng X, Huang F, et al: Survey of
tyrosine kinase signaling reveals ROS kinase fusions in human
cholangiocarcinoma. PLoS One. 6:e156402011. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Singh D, Chan JM, Zoppoli P, et al:
Transforming fusions of FGFR and TACC genes in human glioblastoma.
Science. 337:1231–1235. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Charest A, Lane K, McMahon K, et al:
Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma
with an interstitial del(6) (q21q21). Genes Chromosomes Cancer.
37:58–71. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Burfeind P, Chernicky CL, Rininsland F, et
al: Antisense RNA to the type I insulin-like growth factor receptor
suppresses tumor growth and prevents invasion by rat prostate
cancer cells in vivo. Proc Natl Acad Sci USA. 93:7263–7268. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Shaffer LG, Slovak ML and Campbell LJ:
ISCN 2009: An International System for Human Cytogenetic
Nomenclature. S. Karger; Basel: 2009
|
|
23.
|
Lolait SJ, Harmer JH, Auteri G, et al:
Expression of glial fibrillary acidic protein, actin, fibronectin
and factor VIII antigen in human astrocytomas. Pathology.
15:373–378. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Lipsky RH and Silverman SJ: Effects of
mycophenolic acid on detection of glial filaments in human and rat
astrocytoma cultures. Cancer Res. 47:4900–4904. 1987.PubMed/NCBI
|
|
25.
|
Bocchini V, Casalone R, Collini P, et al:
Changes in glial fibrillary acidic protein and karyotype during
culturing of two cell lines established from human glioblastoma
multiforme. Cell Tissue Res. 265:73–81. 1991. View Article : Google Scholar
|
|
26.
|
Veselska R, Kuglik P, Cejpek P, et al:
Nestin expression in the cell lines derived from glioblastoma
multiforme. BMC Cancer. 6:322003. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Jiang Y and Uhrbom L: On the origin of
glioma. Ups J Med Sci. 117:113–121. 2012. View Article : Google Scholar
|
|
28.
|
Krupkova O, Loja T, Zambo I, et al: Nestin
expression in human tumors and tumor cell lines. Neoplasma.
57:291–298. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Bigner DD, Bigner SH, Ponten J, et al:
Heterogeneity of Genotypic and phenotypic characteristics of
fifteen permanent cell lines derived from human gliomas. J
Neuropathol Exp Neurol. 40:201–229. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Roversi G, Pfundt R, Moroni RF, et al:
Identification of novel genomic markers related to progression to
glioblastoma through genomic profiling of 25 primary glioma cell
lines. Oncogene. 25:1571–1583. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Dahlback HS, Brandal P, Meling TR, et al:
Genomic aberrations in 80 cases of primary glioblastoma multiforme:
Pathogenetic heterogeneity and putative cytogenetic pathways. Genes
Chromosomes Cancer. 48:908–924. 2009. View Article : Google Scholar
|
|
32.
|
Rey JA, Bello MJ, de Campos JM, et al:
Chromosomal patterns in human malignant astrocytomas. Cancer Genet
Cytogenet. 29:201–221. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Bigner SH, Mark J and Bigner DD:
Cytogenetics of human brain tumors. Cancer Genet Cytogenet.
47:141–154. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Kruse CA, Mitchell DH,
Kleinschmidt-DeMasters BK, et al: Characterization of a continuous
human glioma cell line DBTRG-05MG: growth kinetics, karyotype,
receptor expression, and tumor suppressor gene analyses. In Vitro
Cell Dev Biol. 28A:609–614. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Gjerset RA, Fakhrai H, Shawler DL, et al:
Characterization of a new human glioblastoma cell line that
expresses mutant p53 and lacks activation of the PDGF pathway. In
Vitro Cell Dev Biol Anim. 31:207–214. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Cancer Genome Atlas Research Network:
Comprehensive genomic characterization defines human glioblastoma
genes and core pathways. Nature. 455:1061–1068. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Uhrinova S, Uhrin D, Powers H, et al:
Structure of free MDM2 N-terminal domain reveals conformational
adjustments that accompany p53-binding. J Mol Biol. 350:587–598.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Esteller M, Garcia-Foncillas J, Andion E,
et al: Inactivation of the DNA-repair gene MGMT and the clinical
response of gliomas to alkylating agents. N Engl J Med.
343:1350–1354. 2000. View Article : Google Scholar
|
|
39.
|
Hegi ME, Diserens AC, Gorlia T, et al:
MGMT gene silencing and benefit from temozolomide in glioblastoma.
N Engl J Med. 352:997–1003. 2005. View Article : Google Scholar : PubMed/NCBI
|
